191 related articles for article (PubMed ID: 15739619)
1. Current status of anti-SARS agents.
Shigeta S; Yamase T
Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619
[TBL] [Abstract][Full Text] [Related]
2. SARS coronavirus anti-infectives.
Tong TR
Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):297-308. PubMed ID: 18221155
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta 1a and SARS coronavirus replication.
Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
[TBL] [Abstract][Full Text] [Related]
4. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
Tong TR
Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
6. Coronaviruses and their therapy.
Haagmans BL; Osterhaus AD
Antiviral Res; 2006 Sep; 71(2-3):397-403. PubMed ID: 16837072
[TBL] [Abstract][Full Text] [Related]
7. Anti-SARS coronavirus agents: a patent review (2008 - present).
Kumar V; Jung YS; Liang PH
Expert Opin Ther Pat; 2013 Oct; 23(10):1337-48. PubMed ID: 23905913
[TBL] [Abstract][Full Text] [Related]
8. Recent patents on treatment of severe acute respiratory syndrome (SARS).
Zhai S; Liu W; Yan B
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
[TBL] [Abstract][Full Text] [Related]
9. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
[TBL] [Abstract][Full Text] [Related]
10. [Antiretroviral drugs in severe acute respiratory syndrome].
Yazdanpanah Y; Guéry B
Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatment of SARS: current knowledge and recommendations.
Tai DY
Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
[TBL] [Abstract][Full Text] [Related]
13. Treatment of SARS with human interferons.
Antonelli G; Scagnolari C; Vicenzi E; Clementi M
Lancet; 2003 Oct; 362(9390):1158; author reply 1158-9. PubMed ID: 14550714
[No Abstract] [Full Text] [Related]
14. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
[TBL] [Abstract][Full Text] [Related]
15. Infectious diseases. Deferring competition, global net closes in on SARS.
Enserink M; Vogel G
Science; 2003 Apr; 300(5617):224-5. PubMed ID: 12690153
[No Abstract] [Full Text] [Related]
16. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
17. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
Yamamoto N; Yang R; Yoshinaka Y; Amari S; Nakano T; Cinatl J; Rabenau H; Doerr HW; Hunsmann G; Otaka A; Tamamura H; Fujii N; Yamamoto N
Biochem Biophys Res Commun; 2004 Jun; 318(3):719-25. PubMed ID: 15144898
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.
Kao RY; Tsui WH; Lee TS; Tanner JA; Watt RM; Huang JD; Hu L; Chen G; Chen Z; Zhang L; He T; Chan KH; Tse H; To AP; Ng LW; Wong BC; Tsoi HW; Yang D; Ho DD; Yuen KY
Chem Biol; 2004 Sep; 11(9):1293-9. PubMed ID: 15380189
[TBL] [Abstract][Full Text] [Related]
20. Helicases as antiviral drug targets.
Huang JD; Zheng BJ; Sun HZ
Hong Kong Med J; 2008 Aug; 14 Suppl 4():36-8. PubMed ID: 18708673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
